Where is hcg secreted from

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Human chorionic gonadotropin (hCG) is primarily secreted by the syncytiotrophoblast cells of the placenta during pregnancy, starting about 6-8 days after fertilization. It plays a crucial role in maintaining the corpus luteum to support early pregnancy, with levels typically doubling every 48-72 hours in the first trimester.

Key Facts

hCG is first detectable in blood 6-8 days after fertilization
Levels peak at 8-11 weeks of pregnancy at 25,700-288,000 mIU/mL
hCG has a half-life of 24-36 hours in the bloodstream
The hormone consists of two subunits: alpha (92 amino acids) and beta (145 amino acids)
Some non-pregnant conditions like trophoblastic diseases can also produce hCG

Overview

Human chorionic gonadotropin (hCG) is a glycoprotein hormone that plays a pivotal role in human reproduction and pregnancy. First discovered in the 1920s by scientists studying pregnancy physiology, hCG has become one of the most important biomarkers in obstetrics and reproductive medicine. Its discovery revolutionized pregnancy testing and our understanding of early embryonic development.

The hormone's name derives from its origin: "chorionic" refers to the chorion (part of the placenta), and "gonadotropin" indicates its action on the gonads. While primarily associated with pregnancy, hCG has broader significance in medical diagnostics and certain therapeutic applications. Understanding its secretion patterns helps clinicians monitor pregnancy health and detect potential complications.

How It Works

hCG functions through a sophisticated biological mechanism that supports early pregnancy development.

Primary Secretion Source: hCG is secreted by syncytiotrophoblast cells of the developing placenta. These specialized cells begin producing detectable hCG levels approximately 6-8 days after fertilization, coinciding with embryo implantation. Production increases exponentially during early pregnancy, with levels typically doubling every 48-72 hours in the first trimester.
Molecular Structure: The hormone consists of two protein subunits: an alpha subunit (92 amino acids) identical to other glycoprotein hormones, and a unique beta subunit (145 amino acids) that gives hCG its specific biological activity. This beta subunit contains carbohydrate components that affect the hormone's stability and half-life in circulation.
Biological Function: hCG's primary role is to maintain the corpus luteum in the ovary, which produces progesterone to support the uterine lining during early pregnancy. Without hCG, the corpus luteum would degenerate about 14 days after ovulation, leading to menstruation rather than pregnancy continuation.
Secretion Patterns: hCG levels follow a predictable pattern: they become detectable around 6-8 days post-fertilization, peak at 8-11 weeks of pregnancy (typically reaching 25,700-288,000 mIU/mL), then decline and stabilize at lower levels for the remainder of pregnancy. The hormone has a half-life of 24-36 hours in maternal circulation.

Key Comparisons

Feature	Pregnancy hCG	Non-Pregnancy hCG
Primary Source	Placental syncytiotrophoblast cells	Trophoblastic tumors or pituitary gland
Typical Levels	5-50 mIU/mL at 4 weeks, peaking at 25,700-288,000 mIU/mL	Usually <5 mIU/mL in non-pregnant individuals
Clinical Significance	Indicates and monitors pregnancy viability	May indicate trophoblastic disease or other conditions
Doubling Time	48-72 hours in normal early pregnancy	Variable or non-existent in non-pregnancy states
Therapeutic Use	Not typically used therapeutically	Used in fertility treatments to trigger ovulation

Why It Matters

Pregnancy Detection and Monitoring: hCG forms the basis for all modern pregnancy tests, with home tests detecting levels as low as 25 mIU/mL. Serial measurements help assess pregnancy viability, with abnormal doubling times potentially indicating ectopic pregnancy or miscarriage risk. Approximately 1-2% of pregnancies show abnormal hCG patterns requiring medical intervention.
Fertility Treatment Applications: Pharmaceutical hCG injections (containing 5,000-10,000 IU) are used in assisted reproductive technologies to trigger final oocyte maturation. This application has helped millions of couples worldwide overcome infertility, with success rates varying from 20-40% per cycle depending on multiple factors.
Cancer Detection and Monitoring: Elevated hCG in non-pregnant individuals can indicate trophoblastic diseases like hydatidiform mole or choriocarcinoma, which affect approximately 1 in 1,000 pregnancies in the United States. Monitoring hCG levels after treatment helps detect recurrence, with 5-year survival rates exceeding 90% for properly managed cases.

Looking forward, research continues to explore hCG's potential in regenerative medicine and cancer treatment. Some studies suggest hCG may have neuroprotective effects, while others investigate its role in angiogenesis regulation. As our understanding of this remarkable hormone deepens, new diagnostic and therapeutic applications will likely emerge, further cementing hCG's importance in reproductive medicine and beyond. The ongoing refinement of ultra-sensitive detection methods promises even earlier pregnancy detection and more precise monitoring of pregnancy-related conditions.